Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.
Progressive multifocal leukoencephalopathy: cavitary white matter lesions.
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
Gait and six-minute walk performance in persons with multiple sclerosis.
Allogeneic Hematopoietic Stem Cell Transplantation for Neuromyelitis Optica.
Autoimmune disease: A role for new anti-viral therapies?
Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis.
Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature.
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
Is the use of the trivalent influenza vaccine against A (H1N1) pdm09 associated with an increased risk of post-vaccination acute disseminated encephalomyelitis?
Menarche increases relapse risk in pediatric multiple sclerosis.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
Altered serotonin transporter availability in patients with multiple sclerosis.
Fingolimod after natalizumab and the risk of short-term relapse.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Intrathecal versus Oral Baclofen; a Matched Cohort Study of Spasticity, Pain, Sleep, Fatigue and Quality of Life.
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Role of intestinal microbiota in the development of multiple sclerosis.
Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Pages
« first
‹ previous
…
365
366
367
368
369
370
371
372
373
…
next ›
last »